MS-ISPCTN pediatric clinical trials network site (Cycle 3)
Official title: MS-ISPCTN (Cycle 3)
Funded at University of Mississippi Med Ctr · NIH-11394339 · Data updated 2026-11-12
A Mississippi pediatric site is continuing to participate in a national network of pediatric trials to help children’s health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Mississippi Med Ctr NIH-funded |
| Lab location | 1 site (Jackson, United States) |
| Project start | September 23, 2016 |
| Project end | May 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $335,033 |
| NIH project number | 5UG1OD024942-09 |
| Project ID | NIH-11394339 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are children up to 21 years old who may participate in pediatric clinical trials across multiple disease areas.
✕Less likely to help
Some children may not be eligible for specific trials due to age, health status, or study criteria.
What this research studies
This grant supports keeping the Mississippi ECHO ISPCTN site active within the national pediatric trials network, expanding infrastructure, and conducting pediatric trials. The team has built readiness for pediatric research through training, collaboration, and engagement with local communities and leaders. They plan to develop three trial concepts aligned with pediatric health priorities for potential future studies.
Why it matters
Potential benefit: If successful, children in the region could access pediatric trials and benefit from earlier testing of new approaches to common childhood health issues.
How similar studies have gone: The site has already completed seven pediatric trials and continues to build capacity for future trials within the ISPCTN network.
Where this research is happening
-
University of Mississippi Med Ctr
Jackson, United States Active
Researchers
- Principal investigator: Majure, Joseph Marc — University of Mississippi Med Ctr
- Study coordinator: Majure, Joseph Marc
Related research
Other NIH-funded projects on the same topics.
-
Understanding how HTLV-1 hides inside immune cells to drive ATLL
A research project at the University of Mississippi Medical Center is studying how HTLV-1 makes monocytes and macrophages harbor the virus, with the goal of finding ways to restore the body’s own ability to clear it and slow ATL/ATLL progression.
-
Placental support cells and fetal red blood cell quality in preeclampsia
This grant studies how placental support cells in preeclampsia affect the development and quality of a baby’s red blood cells.
-
Epigenetic clues to preeclampsia in pregnancy
This grant explores how epigenetic changes and paternal factors may contribute to preeclampsia, a condition that can affect pregnancy health.
-
Fentanyl use during pregnancy and its effects on mom, placenta, and baby
This project studies how fentanyl use during pregnancy affects a mother's health, the placenta, and the development of the child.
-
Professional Development Core for Clinical & Translational Research in Mississippi
A grant to strengthen clinical and translational research training and community-engaged programs in Mississippi to accelerate care for chronic diseases including diabetes and dementia.
-
RS Core: Support for Clinical Research Development and Population Health in Mississippi
A patient-facing program to help doctors and researchers design and run clinical, translational, and community health studies more effectively.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.